_1777294237270_124456903.png&w=64&q=75){kind=small}
Study links weight loss drugs to male hair loss
A recent study explored a potential link between diabetes and obesity treatments with GLP-1 and hair loss in men, especially those with a genetic predisposition to androgenetic alopecia. The researchers found that increased activity of the GLP1R gene, reflected by a higher number of GLP-1 receptors, is associated with approximately a 7% increase in the risk of hair loss when using medications such as Ozempic, Wegovy, and Zepbound. Although some patients reported hair loss following rapid weight loss after taking these drugs, the results suggest a genetic biological connection between the GLP-1 pathway and hair loss. The findings highlight the importance of conducting further studies to better understand the underlying mechanisms and identify who may be most at risk for these effects, especially given the increasing use of these medications.
Notice: This Is an AI-Generated Summary
Comments (0)